Dr. Robert Lingle, MD
What this data tells you about Dr. Lingle
Dr. Robert Lingle is a cardiovascular disease in Humble, TX, with 16 years in practice. Based on federal Medicare data, Dr. Lingle performed 37,305 Medicare services across 2,697 unique beneficiaries.
Between the years covered by Open Payments, Dr. Lingle received a total of $10,110 from 48 pharmaceutical and/or device companies across 412 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in cardiovascular disease. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Lingle is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Contrast dye for imaging (iodine-based) | 34,496 | $0 | $2 |
| Electrocardiogram (EKG), 12-lead | 387 | $11 | $44 |
| Injection of drug or substance into vein | 351 | $31 | $103 |
| Office visit, established patient (30-39 min) | 254 | $98 | $283 |
| Office visit, established patient (20-29 min) | 243 | $65 | $194 |
| Echocardiogram, transthoracic | 186 | $142 | $534 |
| Ct scan of blood vessels and grafts of heart with contrast | 140 | $227 | $937 |
| Hospital follow-up visit, moderate complexity | 118 | $64 | $188 |
| Ct scan of blood vessels of chest with contrast | 100 | $178 | $787 |
| EKG interpretation and report | 93 | $6 | $22 |
| Regadenoson injection (Lexiscan) for heart stress test | 92 | $45 | $288 |
| Ct scan of blood vessels of abdomen and pelvis with contrast | 74 | $326 | $1,049 |
| CT scan of chest, without contrast | 71 | $75 | $409 |
| Blood draw (venipuncture) | 65 | $8 | $10 |
| Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | 64 | $50 | $189 |
| Technetium tc-99m sestamibi, diagnostic, per study dose | 57 | $81 | $387 |
| New patient office visit (45-59 min) | 56 | $112 | $428 |
| Nuclear medicine studies of heart muscle at rest and with stress and spect | 54 | $352 | $1,272 |
| Lipid panel (cholesterol and triglycerides) | 45 | $13 | $42 |
| Comprehensive metabolic blood panel | 43 | $10 | $36 |
| Complete blood count (CBC) with differential | 39 | $8 | $24 |
| Hospital follow-up visit, high complexity | 38 | $97 | $270 |
| Ct scan of abdominal aorta and both leg arteries with contrast | 37 | $224 | $840 |
| Ct scan of blood vessels of neck with contrast | 36 | $204 | $776 |
| Injection of additional new drug or substance into vein | 35 | $13 | $42 |
| Unclassified drugs | 33 | $1 | $98 |
| Initial hospital admission, moderate complexity | 31 | $101 | $366 |
| Ct scan of heart structure with contrast | 26 | $155 | $645 |
| Low dose ct scan of chest for lung cancer screening | 17 | $110 | $387 |
| Blood creatinine level | 12 | $5 | $16 |
| Urea nitrogen level to assess kidney function, quantitative | 12 | $4 | $13 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (98%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Lingle is a mixed practice specialist, with above-average Medicare volume (top 0% in TX), and low-engagement industry engagement, with 16 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Lingle experienced with contrast dye for imaging (iodine-based)?
Does Dr. Lingle receive payments from pharmaceutical companies?
How do Dr. Lingle's costs compare to other cardiovascular diseases in Humble?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology